Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02111447
Other study ID # 412889-6
Secondary ID
Status Terminated
Phase Phase 4
First received
Last updated
Start date January 2014
Est. completion date December 2014

Study information

Verified date July 2019
Source State University of New York at Buffalo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Children who receive general anesthesia may become agitated (emergence delirium) in the recovery period. This occurs more often after inhalational anesthetics, particularly sevoflurane and desflurane than after propofol. However, agitation after anesthesia in children may be difficult to distinguish from pain; accordingly studies are ideally designed during MRI to obviate the contribution of pain during emergence. Airway complications have been reported after LMA and isoflurane more commonly than with IV propofol and nasal prongs. Whether the airway complications were due to the LMA or the isoflurane was unclear. Therefore, this study was designed to study the incidence of 1. agitation after sevoflurane compared with IV propofol and 2. airway complications after LMA or nasal prongs.


Description:

180 children, ASA physical status 1 or 2 will be recruited for elective MRI scan. Randomized after consent is obtained to one of four groups. Anxiety will be assessed preoperatively using the modified Yale preoperative anxiety scale. Children will be accompanied by one parent to MRI scanner where monitors are applied. All children will have anesthesia induced with nitrous oxide and oxygen followed by sevoflurane until IV is established. Thereupon, they will be managed by their randomization assignment. The propofol pump will be concealed at all times. If propofol was used, it will be disconnected from the patient and residual propofol in the line flushed so prevent unblinding the patient's assignment. A blinded observer will be present to evaluate the patient when emergence begins. The single blinded observer will follow the patient from the MRI scanner through recovery room evaluating vital signs as well as emergence delirium (using the PAED scale). A PAED score > 12 at any time during emergence period will confirm the diagnosis of emergence delirium. After discharge from hospital, a post-discharge questionnaire will be completed at 12, 24 and 48 hours after discharge. All parents will be called to retrieve the questionnaire results after 48 hours after discharge from hospital.


Recruitment information / eligibility

Status Terminated
Enrollment 6
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender All
Age group 2 Years to 12 Years
Eligibility Inclusion Criteria:

- Age 2-12yrs,

- ASA Class I-II,

- Fasting,

- Unmedicated,

- Elective MRI scan

Exclusion Criteria:

- Cognitive impairment,

- On psychotropic medications,

- Taking multiple (>2) antiepileptic medications,

- Requiring endotracheal intubation for GA

Study Design


Intervention

Drug:
Propofol
Propofol infusion with nasal oxygen
Propofol
Propofol infusion with an LMA
Sevoflurane
Sevoflurane with an LMA
Isoflurane
Isoflurane with an LMA

Locations

Country Name City State
United States Women and Chidren's Hospital Of Buffalo Buffalo New York

Sponsors (1)

Lead Sponsor Collaborator
State University of New York at Buffalo

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of Delirium on Emergence Delirium on emergence will be assessed using the PAED scale by a blinded observer in the post anesthesia period. A score >12 constitutes a diagnosis of delirium in children. The post anesthesia period is usually <2 hours after anesthesia. WIthin 2 hours of emergence from anesthesia
Secondary Incidence of Airway Complications All airway reflex responses including airway obstruction breath holding, coughing, laryngospasm, desaturation <92% for >15 s regardless of the cause, bronchospasm, secretions and hiccups WIthin 2 hours of emergence from anesthesia
See also
  Status Clinical Trial Phase
Completed NCT01895023 - Effects of Dexmedetomidine Premedication on Emergence Agitation After Strabismus Surgery in Children Phase 4
Completed NCT04816162 - Ketofol for Preventing Postoperative Delirium in Elderly Patients Phase 4
Active, not recruiting NCT01901588 - Efficacy of Single-Shot Dexmedetomidine Versus Placebo in Preventing Pediatric Emergence Delirium in Strabismus Surgery Phase 4
Completed NCT02509221 - Effect of Duration of Exposure of Anesthesia With Sevoflurane on Emergence Delirium
Completed NCT02489734 - Post Extubation Delirium and End-tidal Sevoflurane Concentration N/A
Completed NCT01680471 - A Study on the Effects of Midazolam on Delirium After Sevoflurane Anesthesia in Pediatric Strabismus Surgery N/A
Recruiting NCT04217915 - A Survey of Management of Analgesia, Sedation and Delirium in ICU Patients in China
Active, not recruiting NCT06176625 - Sight and Hearing Investigation Into Effects on Delirium N/A
Completed NCT03477994 - Efficacy of Dexmedetomidine Versus Clonidine to Control Delirium in Patients Undergoing CABG N/A